Literature DB >> 7548010

Analysis of the structural core of the human estrogen receptor ligand binding domain by selective proteolysis/mass spectrometric analysis.

D A Seielstad1, K E Carlson, P J Kushner, G L Greene, J A Katzenellenbogen.   

Abstract

The structure of the ca. 250 amino acid hormone binding domain of the human estrogen receptor (hER-LBD), expressed in E. coli and purified as a complex with estradiol, has been probed by selective proteolysis, with analysis of the protein fragments both by classical methods (SDS-PAGE and Edman N-terminal sequencing) and by mass spectrometry (HPLC-coupled electrospray ionization mass spectrometry (LC/ESI-MS)). Rapid cleavage by several proteases (trypsin, chymotrypsin, thermolysin, and Asp-N endoproteinase) is observed within a localized region (residues 297-303) at the N-terminus. In contrast, proteolytic scission at the C-terminus is less localized and more progressive; initial cuts by trypsin, chymotrypsin, thermolysin, V8, and Asp-N proteinases are observed to occur in the region 553-571, followed by further cleavage with thermolysin (548) and trypsin (548, 531, and 529). Thus, N304 and K529 define the protease-resistant N- and C-termini of a core structure for this domain that appears to contain the elements sufficient for ligand binding. The remaining segment of this domain (530-553), which is known to embody elements essential for ligand-modulated transcription activation (AF-2), is likely a surface-exposed region that, through these studies, is shown to be accessible to proteases. Only a single region within the 26 kDa ligand-binding core (N304-K529) has been identified as being readily accessible to proteases; rapid proteolysis using the proteases trypsin, chymotrypsin, and thermolysin, is localized to residues 465-468, with cleavage occurring at residues K467, L466, and both T465 and S468, respectively. The flexibility implied by the cuts in this internal 465-468 region suggest that the hER-LBD may actually consist of two subdomains. These proteolysis studies provide a substantially refined view of the conformational nature of the human estrogen receptor ligand binding domain.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7548010     DOI: 10.1021/bi00039a016

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

1.  Mass spectrometry and non-covalent protein-ligand complexes: confirmation of binding sites and changes in tertiary structure.

Authors:  Sharon J Shields; Olayinka Oyeyemi; Felice C Lightstone; Rod Balhorn
Journal:  J Am Soc Mass Spectrom       Date:  2003-05       Impact factor: 3.109

2.  LC-mass spectrometry analysis of N- and C-terminal boundary sequences of polypeptide fragments by limited proteolysis.

Authors:  Justin G Stroh; Pat Loulakis; Anthony J Lanzetti; Julie Xie
Journal:  J Am Soc Mass Spectrom       Date:  2005-01       Impact factor: 3.109

3.  Cloning of a novel receptor expressed in rat prostate and ovary.

Authors:  G G Kuiper; E Enmark; M Pelto-Huikko; S Nilsson; J A Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

4.  Time-resolved limited proteolysis of mitogen-activated protein kinase-activated protein kinase-2 determined by LC/MS only.

Authors:  Li Tao; Susan E Kiefer; Dianlin Xie; James W Bryson; Stanley A Hefta; Michael L Doyle
Journal:  J Am Soc Mass Spectrom       Date:  2008-03-18       Impact factor: 3.109

5.  Electrospray-ionization mass spectrometry of intact intrinsic membrane proteins.

Authors:  J P Whitelegge; C B Gundersen; K F Faull
Journal:  Protein Sci       Date:  1998-06       Impact factor: 6.725

Review 6.  Structural underpinnings of oestrogen receptor mutations in endocrine therapy resistance.

Authors:  John A Katzenellenbogen; Christopher G Mayne; Benita S Katzenellenbogen; Geoffrey L Greene; Sarat Chandarlapaty
Journal:  Nat Rev Cancer       Date:  2018-06       Impact factor: 60.716

7.  The dynamic structure of the estrogen receptor.

Authors:  Raj Kumar; Mikhail N Zakharov; Shagufta H Khan; Rika Miki; Hyeran Jang; Gianluca Toraldo; Rajan Singh; Shalender Bhasin; Ravi Jasuja
Journal:  J Amino Acids       Date:  2011-07-26

8.  Estrogen receptor of primary breast cancers: evidence for intracellular proteolysis.

Authors:  Y Maaroufi; M Lacroix; L Lespagnard; F Journé; D Larsimont; G Leclercq
Journal:  Breast Cancer Res       Date:  2000-09-06       Impact factor: 6.466

9.  Rationally modified estrogen receptor protein as a bio-recognition element for the detection of EDC pollutants: strategies and opportunities.

Authors:  Mattia Pedotti; Valentina Elisabetta Viviana Ferrero; Teresa Lettieri; Pascal Colpo; Stephane Follonier; Luigi Calzolai; Luca Varani
Journal:  Int J Environ Res Public Health       Date:  2015-02-27       Impact factor: 3.390

10.  Regulatory function of the P295-T311 motif of the estrogen receptor alpha - does proteasomal degradation of the receptor induce emergence of peptides implicated in estrogenic responses?

Authors:  Dominique Gallo; Iman Haddad; Guy Laurent; Joëlle Vinh; Françoise Jacquemotte; Yves Jacquot; Guy Leclercq
Journal:  Nucl Recept Signal       Date:  2008-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.